Angiotensin-(1-7) in kidney disease: a review of the controversies
- PMID: 22639821
- DOI: 10.1042/CS20120111
Angiotensin-(1-7) in kidney disease: a review of the controversies
Abstract
Ang-(1-7) [angiotensin-(1-7)] is a biologically active heptapeptide component of the RAS (renin-angiotensin system), and is generated in the kidney at relatively high levels, via enzymatic pathways that include ACE2 (angiotensin-converting enzyme 2). The biological effects of Ang-(1-7) in the kidney are primarily mediated by interaction with the G-protein-coupled receptor Mas. However, other complex effects have been described that may involve receptor-receptor interactions with AT(1) (angiotensin II type 1) or AT(2) (angiotensin II type 2) receptors, as well as nuclear receptor binding. In the renal vasculature, Ang-(1-7) has vasodilatory properties and it opposes growth-stimulatory signalling in tubular epithelial cells. In several kidney diseases, including hypertensive and diabetic nephropathy, glomerulonephritis, tubulointerstitial fibrosis, pre-eclampsia and acute kidney injury, a growing body of evidence supports a role for endogenous or exogenous Ang-(1-7) as an antagonist of signalling mediated by AT(1) receptors and thereby as a protector against nephron injury. In certain experimental conditions, Ang-(1-7) appears to paradoxically exacerbate renal injury, suggesting that dose or route of administration, state of activation of the local RAS, cell-specific signalling or non-Mas receptor-mediated pathways may contribute to the deleterious responses. Although Ang-(1-7) has promise as a potential therapeutic agent in humans with kidney disease, further studies are required to delineate its signalling mechanisms in the kidney under physiological and pathophysiological conditions.
Similar articles
-
Angiotensin-(1-7): beyond the cardio-renal actions.Clin Sci (Lond). 2013 Apr;124(7):443-56. doi: 10.1042/CS20120461. Clin Sci (Lond). 2013. PMID: 23249272 Review.
-
Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.Clin Sci (Lond). 2015 May 1;128(10):649-63. doi: 10.1042/CS20140329. Clin Sci (Lond). 2015. PMID: 25495544
-
[Effects of ACE2-Ang 1-7-Mas axis on blood vessel].Sheng Li Ke Xue Jin Zhan. 2007 Jan;38(1):43-8. Sheng Li Ke Xue Jin Zhan. 2007. PMID: 17438952 Review. Chinese.
-
Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.Gastroenterology. 2013 Oct;145(4):874-884.e5. doi: 10.1053/j.gastro.2013.06.036. Epub 2013 Jun 22. Gastroenterology. 2013. PMID: 23796456
-
ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.Pharmacol Res. 2016 May;107:154-162. doi: 10.1016/j.phrs.2016.03.018. Epub 2016 Mar 17. Pharmacol Res. 2016. PMID: 26995300 Review.
Cited by
-
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.Front Pharmacol. 2024 Aug 21;15:1394997. doi: 10.3389/fphar.2024.1394997. eCollection 2024. Front Pharmacol. 2024. PMID: 39234105 Free PMC article. Review.
-
Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1-7)/MasR signaling in normal and hypertensive pregnancy.Biochem Pharmacol. 2024 Feb;220:115963. doi: 10.1016/j.bcp.2023.115963. Epub 2023 Dec 5. Biochem Pharmacol. 2024. PMID: 38061417 Review.
-
Renal vascular responses to angiotensin II infusion in two kidneys-one clip hypertensive rats under partial ischemia/reperfusion with and without ischemia preconditioning: the roles of AT1R blockade and co-blockades of AT1R and MasR.Res Pharm Sci. 2023 Jun 1;18(4):392-403. doi: 10.4103/1735-5362.378086. eCollection 2023 Jul-Aug. Res Pharm Sci. 2023. PMID: 37614612 Free PMC article.
-
Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system.Front Endocrinol (Lausanne). 2022 Dec 23;13:1080285. doi: 10.3389/fendo.2022.1080285. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36619582 Free PMC article. Review.
-
View of the Renin-Angiotensin System in Acute Kidney Injury Induced by Renal Ischemia-Reperfusion Injury.J Renin Angiotensin Aldosterone Syst. 2022 Oct 22;2022:9800838. doi: 10.1155/2022/9800838. eCollection 2022. J Renin Angiotensin Aldosterone Syst. 2022. PMID: 36320442 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous